NCT01710319View on ClinicalTrials.gov

Mechanisms of Immunosurveillance for Lung Cancer

CompletedOBSERVATIONAL
Enrollment

119

Participants

Timeline

Start Date

September 30, 2012

Primary Completion Date

July 7, 2016

Study Completion Date

July 7, 2016

Conditions
Lung Cancer
Interventions
OTHER

blood draw

a blood specimen will be obtained from each patient in the four groups. An optional blood draw after 30 days of initial blood specimen if indicated.

Trial Locations (1)

63110

Washington University School of Medicine, St Louis

All Listed Sponsors
collaborator

Saint Louis VA Medical Center

FED

lead

Washington University School of Medicine

OTHER

NCT01710319 - Mechanisms of Immunosurveillance for Lung Cancer | Biotech Hunter | Biotech Hunter